Inhibrx shares owned by Goldman Sachs Group
Historical chart of Goldman Sachs Group investment in Inhibrx
Tip: Access up to 7 years of quarterly data
All positions including Inhibrx held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibrx by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.8M | 153k | 38.00 |
| 2023-09-30 | $2.9M | 160k | 18.35 |
| 2023-06-30 | $6.5M | 250k | 25.96 |
| 2023-03-31 | $3.3M | 175k | 18.87 |
| 2022-12-31 | $4.2M | 172k | 24.64 |
| 2022-06-30 | $914k | 80k | 11.36 |
| 2022-03-31 | $3.2M | 145k | 22.28 |
| 2021-12-31 | $5.3M | 122k | 43.65 |
| 2021-09-30 | $5.5M | 165k | 33.31 |
| 2021-03-31 | $855k | 43k | 20.08 |
| 2020-12-31 | $413k | 13k | 33.00 |
| 2020-09-30 | $1.6M | 90k | 18.00 |